Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands: The truth behind the rates

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 4, 1998, Pages 296-302

  Lambregts van Weezenbeek, C S B ^a   Jansen, H M ^b   Veen, J ^a   Nagelkerke, N J D ^a   Sebek, M M G G ^a   Van Soolingen, D ^c  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Case management; Programme monitoring; Resistance; Surveillance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DEMOGRAPHY; DISEASE PREDISPOSITION; DNA FINGERPRINTING; DRUG SENSITIVITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MIGRATION; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; PATIENT CARE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CONTACT TRACING; DNA FINGERPRINTING; EMIGRATION AND IMMIGRATION; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0031981920     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lambregts-van Weezenbeek C S B, Veen J. Control of drug-resistant tuberculosis. Tubercle Lung Dis 1995; 76: 375-473.
2. Cohn D L, Bustreo F, Raviglione M C. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997; 24(Suppl 1): S121-130.
3. Tuberculosis Programme World Health Organization, Geneva, and International Union Against Tuberculosis and Lung Dis- ease, Paris. Guidelines for surveillance of drug resistance in tuberculosis. WHO TB/94.178.
4. Boulahbal F, Khaled S, Tazir M. The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme. Bull Int Union Tuberc Lung Dis 1989; 64: 23-25.
5. Chaulet P, Boulahbal F, Grosset J. Surveillance of drug resistance for tuberculosis control: why and how? Tubercle Lung Dis 1995; 76: 487-492.
6. Lambregts-van Weezenbeek C S B, Jansen H M, Nagelkerke N J D, van Klingeren B, Veen J. Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: rates, risk factors and treatment outcome. Int J Tuberc Lung Dis 1998; 2: 288-295.
7. Van Soolingen D, de Haas P E W, Hermans P W M, Groenen P M A, van Embden J D A. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1993; 31: 1987-1995.
8. de Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 1995; 76: 425-430.
9. Van Soolingen D, Lambregts-van Weezenbeek C S B, De Haas P, Veen J, van Embden J D A. Transmissie van gevoelige en resistente Mycobacterium tuberculosis-stammen in Nederland, 1993-1995, onderzocht met DNA-'fingerprinting'. Ned Tijdschr Geneeskd 1996; 140 (46): 2286-2289.
10. Lambregts-van Weezenbeek C S B, Keizer S T, Sebek M M G G, Schepp-Beelen J C H M, Van der Loo C J. Transmissie van multi-resistente tuberculose in een Nederlands ziekenhuis. Ned Tijdschr Geneeskd 1996; 140 (46): 2293-2295.